FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.
Released May 22, 2017
FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Recommended
Details
Overview
FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.
Released May 22, 2017
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE Broadcast Replay
Pulmonary Hypertension Management: Practice Trends and Updates
1.00 credits
<p>Pulmonary Hypertension Management: Practice Trends and Updates</p>
MinuteCE®
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
0.75 credits
<p><span data-contrast="auto" style="list-style-type: disc;" xml:lang="EN-US">Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies</span></p>
MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC</span></p>
Advances in Women's Health
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
<p>Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression</p>
Advances in Women's Health
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
<p>Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients</p>
Advances in Women's Health
Reducing the Risk of Postpartum Depression Through Sleep Interventions
<p>Reducing the Risk of Postpartum Depression Through Sleep Interventions<strong> </strong></p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?